Persistent Diarrhea and Eosinophilic Esophagitis Resulting From Chronic Cannabidiol Usage for Refractory Epilepsy
Article 2022 en
Authors
MP
Maitri M. Patel
JM
Jeremy P. Middleton
HG
Howard P. Goodkin
Abstract
1 min read
Cannabidiol is used in the care of treatment-resistant epilepsy. It has been associated with varying side effects, ranging from somnolence to diarrhea and weight loss. We present a patient on chronic cannabidiol therapy who had persistent diarrhea, abdominal pain, weight loss, and esophageal eosinophilia that improved with cannabidiol dose adjustment.
Shahneen Sandhu, Julia Elizabeth Lai-Kwon, Ashkan Mehrnejad, Mustafa Abdi Mohamed, Kortnye Smith, Lavinia Spain, Aparna D. Rao, Belinda Lee, George Au‐Yeung, Allison Drosdowsky, Karla Gough, Michael Jefford
Michael D. Jensen, Donna H. Ryan, Karen A. Donato, Caroline M. Apovian, Jamy D. Ard, Anthony G. Comuzzie, Frank B Hu, Van S. Hubbard, John M. Jakicic, Robert F. Kushner, Catherine M. Loria, Barbara E. Millen, Cathy Nonas, F. Xavier Pi‐Sunyer, June Stevens, Victor J. Stevens, Thomas A. Wadden, Bruce M. Wolfe, Jack A. Yanovski
Graham Devereux, Seonaidh Cotton, Shona Fielding, Nicola McMeekin, Peter J Barnes, Andrew Briggs, Graham Burns, Rekha Chaudhuri, Henry Chrystyn, Lisa Davies, Anthony De Soyza, Simon Gompertz, John Haughney, Karen Innes, Joanna Kaniewska, Amanda Lee, Alyn H. Morice, John Norrie, A. Sullivan, Andrew M. Wilson, David Price
Discussion(0)
No comments yet. Be the first to comment.